Patrick Trucchio
Stock Analyst at HC Wainwright & Co.
(1.81)
# 3,064
Out of 4,732 analysts
305
Total ratings
28.38%
Success rate
-8.92%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Patrick Trucchio
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| HRMY Harmony Biosciences Holdings | Reiterates: Buy | $75 | $39.05 | +92.06% | 2 | Jan 16, 2025 | |
| ALNY Alnylam Pharmaceuticals | Reiterates: Buy | $400 | $246.27 | +62.42% | 23 | Jan 13, 2025 | |
| GHRS GH Research | Reiterates: Buy | $40 | $8.88 | +350.45% | 13 | Jan 13, 2025 | |
| DRUG Bright Minds Biosciences | Initiates: Buy | $85 | $36.78 | +131.10% | 1 | Jan 10, 2025 | |
| DTIL Precision BioSciences | Reiterates: Buy | $60 | $4.96 | +1,109.68% | 14 | Jan 10, 2025 | |
| VIR Vir Biotechnology | Reiterates: Buy | $110 | $10.11 | +988.03% | 21 | Jan 10, 2025 | |
| SGMO Sangamo Therapeutics | Reiterates: Buy | $10 | $1.09 | +817.43% | 23 | Jan 2, 2025 | |
| ARWR Arrowhead Pharmaceuticals | Reiterates: Buy | $80 | $19.56 | +309.00% | 20 | Dec 20, 2024 | |
| QURE uniQure | Reiterates: Buy | $25 | $14.05 | +77.94% | 11 | Dec 10, 2024 | |
| BEAM Beam Therapeutics | Reiterates: Buy | $80 | $23.44 | +241.30% | 4 | Dec 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $75 | $5.12 | +1,364.84% | 20 | Dec 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $15 → $10 | $0.41 | +2,360.63% | 14 | Nov 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $190 | $9.13 | +1,981.05% | 15 | Nov 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $15 → $10 | $1.46 | +584.93% | 14 | Nov 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $5 | $0.79 | +532.11% | 15 | Nov 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $12 | $6.86 | +74.93% | 12 | Nov 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $30 | $5.07 | +491.72% | 6 | Nov 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $10 | $0.96 | +939.61% | 14 | Nov 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $55 | $7.16 | +668.69% | 16 | Nov 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $120 → $60 | $3.49 | +1,619.20% | 12 | Nov 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $100 | $29.02 | +244.59% | 16 | Oct 24, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $25 | $1.98 | +1,162.63% | 14 | Oct 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $170 → $68 | $10.30 | +560.19% | 2 | Sep 23, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $230 → $20 | $0.86 | +2,237.81% | 2 | Dec 28, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $260 → $340 | $242.05 | +40.47% | 1 | Aug 18, 2021 |
Harmony Biosciences Holdings
Jan 16, 2025
Reiterates: Buy
Price Target: $75
Current: $39.05
Upside: +92.06%
Alnylam Pharmaceuticals
Jan 13, 2025
Reiterates: Buy
Price Target: $400
Current: $246.27
Upside: +62.42%
GH Research
Jan 13, 2025
Reiterates: Buy
Price Target: $40
Current: $8.88
Upside: +350.45%
Bright Minds Biosciences
Jan 10, 2025
Initiates: Buy
Price Target: $85
Current: $36.78
Upside: +131.10%
Precision BioSciences
Jan 10, 2025
Reiterates: Buy
Price Target: $60
Current: $4.96
Upside: +1,109.68%
Vir Biotechnology
Jan 10, 2025
Reiterates: Buy
Price Target: $110
Current: $10.11
Upside: +988.03%
Sangamo Therapeutics
Jan 2, 2025
Reiterates: Buy
Price Target: $10
Current: $1.09
Upside: +817.43%
Arrowhead Pharmaceuticals
Dec 20, 2024
Reiterates: Buy
Price Target: $80
Current: $19.56
Upside: +309.00%
uniQure
Dec 10, 2024
Reiterates: Buy
Price Target: $25
Current: $14.05
Upside: +77.94%
Beam Therapeutics
Dec 9, 2024
Reiterates: Buy
Price Target: $80
Current: $23.44
Upside: +241.30%
Dec 9, 2024
Reiterates: Buy
Price Target: $75
Current: $5.12
Upside: +1,364.84%
Nov 20, 2024
Maintains: Buy
Price Target: $15 → $10
Current: $0.41
Upside: +2,360.63%
Nov 19, 2024
Reiterates: Buy
Price Target: $190
Current: $9.13
Upside: +1,981.05%
Nov 18, 2024
Maintains: Buy
Price Target: $15 → $10
Current: $1.46
Upside: +584.93%
Nov 14, 2024
Reiterates: Buy
Price Target: $5
Current: $0.79
Upside: +532.11%
Nov 14, 2024
Reiterates: Buy
Price Target: $12
Current: $6.86
Upside: +74.93%
Nov 14, 2024
Reiterates: Buy
Price Target: $30
Current: $5.07
Upside: +491.72%
Nov 11, 2024
Reiterates: Buy
Price Target: $10
Current: $0.96
Upside: +939.61%
Nov 11, 2024
Reiterates: Buy
Price Target: $55
Current: $7.16
Upside: +668.69%
Nov 1, 2024
Maintains: Buy
Price Target: $120 → $60
Current: $3.49
Upside: +1,619.20%
Oct 24, 2024
Reiterates: Buy
Price Target: $100
Current: $29.02
Upside: +244.59%
Oct 14, 2024
Reiterates: Buy
Price Target: $25
Current: $1.98
Upside: +1,162.63%
Sep 23, 2022
Maintains: Buy
Price Target: $170 → $68
Current: $10.30
Upside: +560.19%
Dec 28, 2021
Maintains: Buy
Price Target: $230 → $20
Current: $0.86
Upside: +2,237.81%
Aug 18, 2021
Maintains: Outperform
Price Target: $260 → $340
Current: $242.05
Upside: +40.47%